Effect of advanced chronic kidney disease in clinical and echocardiographic outcomes of patients treated with MitraClip system.

[1]  C. Ronco,et al.  Chronic kidney disease and cardiovascular complications , 2015, Heart Failure Reviews.

[2]  D. Capodanno,et al.  Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. , 2014, European heart journal cardiovascular Imaging.

[3]  K. Kuck,et al.  Percutaneous mitral valve repair with the mitraclip system according to the predicted risk by the logistic EuroSCORE: Preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  M. Najafi.  Serum creatinine role in predicting outcome after cardiac surgery beyond acute kidney injury. , 2014, World journal of cardiology.

[5]  S. Blankenberg,et al.  Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. , 2014, Journal of the American College of Cardiology.

[6]  M. Post,et al.  Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. , 2014, JACC. Cardiovascular interventions.

[7]  M. Mack,et al.  Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. , 2014, Journal of the American College of Cardiology.

[8]  S. Blankenberg,et al.  MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome. , 2014, JACC. Cardiovascular interventions.

[9]  Patric Biaggi,et al.  Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome , 2014, Open Heart.

[10]  N. Weissman,et al.  Relationship Between the Magnitude of Reduction in Mitral Regurgitation Severity and Left Ventricular and Left Atrial Reverse Remodeling After MitraClip Therapy , 2013, Circulation.

[11]  K. Phan,et al.  A meta-analysis of MitraClip system versus surgery for treatment of severe mitral regurgitation. , 2013, Annals of cardiothoracic surgery.

[12]  J. Hausleiter,et al.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. , 2013, Journal of the American College of Cardiology.

[13]  E. Foster,et al.  4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. , 2013, Journal of the American College of Cardiology.

[14]  C. Nienaber,et al.  Residual mitral valve regurgitation after percutaneous mitral valve repair with the mitraclip® system is a risk factor for adverse one‐year outcome , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  V. Fuster,et al.  Management of cardiovascular disease in patients with kidney disease , 2013, Nature Reviews Cardiology.

[16]  K. Rufibach,et al.  Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry , 2013, Heart.

[17]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[18]  E. Foster,et al.  Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. , 2012, Journal of the American College of Cardiology.

[19]  Jean-Louis Vanoverschelde,et al.  EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  J. Gorman,et al.  Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.

[21]  M. Keane,et al.  EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[22]  Jean-Louis Vanoverschelde,et al.  EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. , 2011, European heart journal.

[23]  J. Zamorano,et al.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[24]  O. Alfieri,et al.  Long‐term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction , 2009, European journal of heart failure.

[25]  G. Filippatos,et al.  [Guidelines on the management of valvular heart disease]. , 2013, Revista espanola de cardiologia.

[26]  Randolph P. Martin,et al.  Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[27]  E. Schiffrin,et al.  Chronic Kidney Disease: Effects on the Cardiovascular System , 2007, Circulation.

[28]  Philippe Ravaud,et al.  What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? , 2007, European heart journal.

[29]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[30]  F. Verheugt,et al.  Estimated creatinine clearance instead of plasma creatinine level as prognostic test for postoperative renal function in patients undergoing coronary artery bypass surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[31]  Torsten Doenst,et al.  Chronic ischemic mitral regurgitation: repair, replace or rethink? , 2006, The Annals of thoracic surgery.

[32]  E. Foster,et al.  Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. , 2005, Journal of the American College of Cardiology.

[33]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[34]  C. O'connor,et al.  Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. , 2003, The American journal of cardiology.

[35]  F. Grover,et al.  Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Database Committee of The Society of Thoracic Surgeons. , 1999, The Annals of thoracic surgery.

[36]  J B Seward,et al.  Clinical outcome of mitral regurgitation due to flail leaflet. , 1996, The New England journal of medicine.

[37]  P. Kligfield,et al.  Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. , 1994, The American journal of cardiology.

[38]  P. Parfrey,et al.  The clinical course of left ventricular hypertrophy in dialysis patients. , 1990, Nephron.